Emergence of HER2‐targeted agents has revolutionary significance in the treatment of HER2‐positive breast cancer.2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14. The gene discussed is ERBB2; the disease is breast cancer.